As we are counting the days for 2019, let’s share our expectations from New Year in terms of Pharma market …
- Global Market growth (both volume and value)
- US Drug Pricing reform
- Impact of Brexit on product supply (shortage)
- More China News
- Less EM
- More gene therapies & stem cell-based therapies
- Less Immuno-oncology
- Few market share acquisition of Biosimilars
- M&A activities helped by US tax reform/overseas earning repatriation
- Further Digitalization both on R&D and prevention & treatment side (healthcare technologies – apps & sensors)
- Minimum one MEGA Merger (>$50BN)
Merry Xmas & Happy New Year !!!